These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. [Recombinant murine cell lines, transformed by various vectors based on bovine type 1 papillomavirus and expressing human tissue plasminogen activator. II. Analysis of cell lines, producing recombinant tissue plasminogen activator]. Aleshkov SB; Ustav MB; Baev AA Mol Biol (Mosk); 1994; 28(3):619-25. PubMed ID: 8052253 [TBL] [Abstract][Full Text] [Related]
18. Serpin-resistant mutants of human tissue-type plasminogen activator. Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599 [TBL] [Abstract][Full Text] [Related]
19. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727 [TBL] [Abstract][Full Text] [Related]
20. EPO patient dispute: court battle ends at the start. Gershon D Nature; 1989 Dec 21-28; 342(6252):846. PubMed ID: 2594071 [No Abstract] [Full Text] [Related] [Next] [New Search]